Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

July
10
2018

Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions

BOCA RATON, Fla., July 10, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical,…

July
06
2018

People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries

Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses…

July
01
2018

 Skin Cancer and SRT – Jeff Goldstein Interview

All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer…

June
26
2018

Utilizing the SRT Keloid Treatment To Help Change Lives

The SRT Keloid Treatment helps to change lives. To show you just how effective SRT can be for keloids, we wanted to share the story of a patient who was successfully treated with the SRT-100….

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry